CSHL Stories and Media archive for Tag: RNA splicing

Learn about the cool campus artwork at CSHL

Different structures and artworks around campus hint at a history of groundbreaking molecular science. Take the quiz »

This killer protein causes pancreatic cancer

4/26/2023

CSHL researchers have found that high levels of a protein called SRSF1 can cause pancreatitis and jumpstart tumor development. Read the story »

Krainer named Society for RNA Therapeutics board member

4/18/2023

He helped pioneer the field. It changed medicine. Now, he joins a group of renowned scientists and physicians aiming to take it to the next level. Read the story »

From tragedy, a potential pediatric cancer treatment

4/12/2023

CSHL Professor Adrian Krainer, the man behind the “miracle drug” known as Spinraza®, has found a way to fight a deadly pediatric brain cancer in mice. Read the story »

A new treatment approach for cystic fibrosis

7/14/2022

Molecules called antisense oligonucleotides may help lung cells make a protein missing in people with cystic fibrosis. Read the story »

Krainer awarded Watanabe Prize in Translational Research

6/16/2022

Indiana University School of Medicine honored Krainer for his pioneering work on RNA splicing, which led to the first FDA-approved SMA therapeutic. Read the story »

Cutting off liver cancer’s nutrient supply chain

2/3/2022

CSHL researchers developed a way to interfere with the energy pathway that allows liver cancer to grow and spread. Read the story »

Editing RNA to fix protein problems in cystic fibrosis

1/27/2022

CSHL researchers found a new way to address a previously untreatable class of mutations in the cystic fibrosis gene. Read the story »

The rise of RNA therapeutics

10/14/2021

RNA has been making waves as a new approach to prevent or treat diseases, including COVID-19 and spinal muscular atrophy. Read the story »

Krainer wins Pew grant to study fetal alcohol syndrome

9/15/2021

CSHL Professor Adrian Krainer will study RNA splicing errors that occur in people with the disease and look for treatment targets. Read the story »

Adenovirus: After 40 years, a call to arms

5/21/2021

Virus research done 40 years ago at CSHL provided an early foundation for today’s adenovirus-based treatments and vaccines. Read the story »

Krainer wins 2021 Wolf Prize in Medicine

2/17/2021

CSHL Professor Adrian Krainer was awarded the 2021 Wolf Prize in Medicine for his work on RNA splicing. Read the story »

Krainer wins 2020 NYAS Innovators prize for SMA research

7/8/2020

Professor Adrian Krainer is the 2020 Senior Scientist Winner of the Innovators in Science Award for his work on SPINRAZA^®. Read the story »

Adrian Krainer elected to the National Academy of Sciences

4/28/2020

Professor Adrian Krainer was elected to the National Academy of Science as part of its 2020 election. Read the story »

Humans of Banbury: Interview with Stephen Kaler

4/15/2020

An interview with March’s "Copper Cancer Consortium" meeting participant Stephen Kaler, M.D., M.P.H. Read the story »